Form 8-K - Current report:
SEC Accession No. 0000920148-25-000021
Filing Date
2025-02-06
Accepted
2025-02-06 06:54:01
Documents
15
Period of Report
2025-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lh-20250206.htm   iXBRL 8-K 26448
2 EX-99.1 form8-kerex991for4q24.htm EX-99.1 495221
6 labcorp_logoxhorizontalxcoa.jpg GRAPHIC 110565
  Complete submission text file 0000920148-25-000021.txt   824041

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lh-20250206.xsd EX-101.SCH 2054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lh-20250206_lab.xml EX-101.LAB 22141
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lh-20250206_pre.xml EX-101.PRE 12814
17 EXTRACTED XBRL INSTANCE DOCUMENT lh-20250206_htm.xml XML 2699
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 25595394
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)